Clinical Trials Sponsored by Chugai Pharmaceutical Co.

Total 4075 results

AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (MATEO)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

Germany
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM

Hypercalcemia of Malignancy
Peking University First Hospital
Jiangsu Wanbang Pharmaceutical Marketing Co.,Ltd.

Unknown

Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris

Coronary Heart Disease

China
Beijing Tiantan Hospital
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Endostatin)

Neurofibromatosis Type 2 | Vestibular Schwannoma

China
Zhejiang University
Beta Pharma, Inc.; Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Lung Cancer

China
The Second People's Hospital of Sichuan
Biotech Pharmaceutical Co., Ltd.

Unknown

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

Hypopharyngeal Cancer | Oropharyngeal Cancer

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing University of Chinese Medicine

Unknown

A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease

Hand, Foot and Mouth Disease

China
Qiang Fu
Yangtze River Pharmaceutical Group Co., Ltd.

Not yet recruiting

Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules (CRF)

Cancer-related Fatigue
Peking Union Medical College Hospital
Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Recruiting

Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) (WU-KONG15)

Non Small Cell Lung Cancer

China
Yooyoung Pharmaceutical Co., Ltd.
Opera CRO, a TIGERMED Group Company

Not yet recruiting

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of ORTHIX PLUS

Osteoarthritis, Knee | Degenerative Joint Disease of Knee
Yooyoung Pharmaceutical Co., Ltd.
Opera CRO, a TIGERMED Group Company

Not yet recruiting

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO

Osteoarthritis | Degenerative Joint Disease
Peking Union Medical College Hospital
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis

Knee Osteoarthritis

China
Xinqiao Hospital of Chongqing
CSPC RECOMGEN PHARMACEUTICAL (GUANGZHOU) CO.,LTD

Recruiting

Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke (BRIDGE-TNK)

Stroke, Ischemic | Stroke, Acute

China
China-Japan Friendship Hospital
Guangxi Wuzhou Pharmaceutical (GROUP) Co., Ltd.

Active, not recruiting

Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients

Thromboembolism | Venous Thromboembolism (VTE)

China
Sihuan Pharmaceutical Holdings Group Ltd.
Covance; XuanZhu Pharma Co., Ltd.

Completed

A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Henan Cancer Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Active, not recruiting

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

Esophageal Squamous Cell Carcinoma

China
AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction (S-1 adjuvant)

Adenocarcinoma,Stomach | Adenocarcinoma, Esophagogastric Junction

Germany
Panion & BF Biotech Inc.
Shandong Weigao Panion Pharmaceutical Co. Ltd.

Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

End Stage Renal Disease | ESRD | Hyperphosphatemia

China
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Ajou University School of Medicine
Dong-A Pharmaceutical Co., Ltd.

Completed

Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS)

Ischemic Stroke | Angiogenesis
Henan Cancer Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Non-squamous Cell Non-Small Cell Lung Cancer

China
Peking University People's Hospital
Yichang Humanwell Pharmaceutical Co., Ltd., China

Unknown

Impact of CYP3A4*1G Polymorphism on Non-analgesic Effects of Fentanyl in Chinese Han Patients

Fentanyl

China
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital

Unknown

Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC

Metastatic Non-small Cell Lung Cancer

China
Second Affiliated Hospital of Soochow University
Qilu Pharmaceutical Co., Ltd.

Unknown

Idebenone Treatment of Early Parkinson's Diseasesymptoms (ITEP)

Oxidative Stress is an Important Cause of Parkinson's Disease
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects

Healthy Volunteer

China
Guizhou Bailing Group Pharmaceutical Co Ltd
China-Japan Friendship Hospital

Completed

Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule (TNTL)

Accidental Exposure While Preparing Drug for Administration

China
Hyuk moon Kim
Dong-A Pharmaceutical Co., Ltd.

Unknown

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Neutropenia

Korea, Republic of
Nang Kuang Pharmaceutical Co., Ltd.
Buddhist Tzu Chi General Hospital

Completed

A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain

Depression | Pain

Taiwan
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Recruiting

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

SARS-CoV-2

China
The First Affiliated Hospital of Zhengzhou University
BeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.

Not yet recruiting

Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy

HER2-positive or Mutated Advanced Colorectal Cancer
The First Affiliated Hospital of Soochow University
Biotech Pharmaceutical Co., Ltd.; Cinda Biopharmaceutical (Suzhou) Co., Ltd.

Not yet recruiting

Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. (Carpp-1)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Not yet recruiting

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

SARS-CoV-2
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
ASLAN Pharmaceuticals
Syneos Health; bioRASI, LLC; CMIC Co, Ltd. Japan

Completed

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer (TreeTopp)

Biliary Tract Cancer

United States, Australia, China, Hong Kong, Hungary, Japan, Korea, Republic of, Poland, Singapore, Spain, Taiwan
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Completed

Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects (RTV)

Healthy Volunteer

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Dry Eye Disease

China
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Terminated

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

2019-nCoV

China
AOP Orphan Pharmaceuticals AG
PharmaEssentia Corporation (Co-Sponsor for USA)

Completed

Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients (PEN-PV)

Polycythemia Vera

Austria, Bulgaria, Czech Republic, France, Hungary, Poland, Slovakia, Ukraine
GeneScience Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology

Completed

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children (Phase 1)

Growth Hormone Deficiency
Yunpeng Liu
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma

Biliary Tract Carcinoma

China
Sun Yat-sen University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

First-line Anlotinib Combined With Penpulimab for Advanced Pheochromocytoma: A Single-arm, Multicenter, Prospective Phase II Study

Pheochromocytoma

China
Beijing Union Pharmaceutical Factory Ltd
R&G Pharma Studies Co.,Ltd.

Recruiting

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD (BGFN-2022-01)

Generalized Anxiety Disorder

China
Xi'An Aolitai Pharmaceutical Technology Co Ltd

Recruiting

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Drug-Induced Liver Injury | Cholestatic Liver Injury | Mixed Liver Injury

China
Jae Myung Park
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients (NSAID)

Osteoarthritis
Jung Im Jung
Taejoon Pharmaceutical Co., Ltd.

Recruiting

Chest CT Using Low-concentration Iodine Contrast Media

Pulmonary Disease

Korea, Republic of
Asan Medical Center
Korean Cancer Study Group; Boryung Pharmaceutical Co., Ltd

Recruiting

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer (BRISK)

Advanced Solid Tumors | Metastatic Cancer | Solid Tumors

Korea, Republic of

Clinical Trials Sponsored by Chugai Pharmaceutical Co.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations